CryoPort Inc (CYRX) Rating Reiterated by Cowen and Company
CryoPort Inc (OTCMKTS:CYRX)‘s stock had its “outperform” rating restated by stock analysts at Cowen and Company in a report released on Friday. They presently have a $5.50 price objective on the consumer goods maker’s stock. Cowen and Company’s price target would suggest a potential upside of 17.52% from the stock’s current price.
CYRX has been the topic of several other research reports. Needham & Company LLC raised their target price on CryoPort from $3.50 to $4.50 and gave the company a “buy” rating in a research report on Thursday, June 1st. ValuEngine upgraded CryoPort from a “sell” rating to a “hold” rating and set a $122.00 target price on the stock in a research report on Friday, May 12th.
CryoPort (CYRX) opened at 4.68 on Friday. CryoPort has a 12-month low of $1.50 and a 12-month high of $4.75. The stock’s market capitalization is $112.20 million. The company has a 50-day moving average price of $3.35 and a 200-day moving average price of $3.12.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
Receive News & Ratings for CryoPort Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc and related companies with MarketBeat.com's FREE daily email newsletter.